Maxion Therapeutics
Maxion Therapeutics
maxiontherapeutics.com

Locations

Streetly End, Cambridge CB21 4RP, UK

industry

Biotechnology

Size

11-50 employees

Stage

Series A

founded in

2020

Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

Something looks off?
Open jobs at Maxion Therapeutics

On-site & Remote